- Home
- EVGN vs PMCB Comparison
EVGN vs PMCB Comparison
Compare EVGN & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- PMCB
- Stock Information
- Founded
- EVGN 1999
- PMCB 1996
- Country
- EVGN Israel
- PMCB United States
- Employees
- EVGN N/A
- PMCB N/A
- Industry
- EVGN Agricultural Chemicals
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVGN Industrials
- PMCB Health Care
- Exchange
- EVGN Nasdaq
- PMCB Nasdaq
- Market Cap
- EVGN 9.7M
- PMCB 11.4M
- IPO Year
- EVGN N/A
- PMCB N/A
- Fundamental
- Price
- EVGN $1.27
- PMCB $1.30
- Analyst Decision
- EVGN Strong Buy
- PMCB
- Analyst Count
- EVGN 1
- PMCB 0
- Target Price
- EVGN $12.00
- PMCB N/A
- AVG Volume (30 Days)
- EVGN 17.4K
- PMCB 15.1K
- Earning Date
- EVGN 03-06-2025
- PMCB 03-17-2025
- Dividend Yield
- EVGN N/A
- PMCB N/A
- EPS Growth
- EVGN N/A
- PMCB N/A
- EPS
- EVGN N/A
- PMCB 1.29
- Revenue
- EVGN $8,511,000.00
- PMCB N/A
- Revenue This Year
- EVGN $74.97
- PMCB N/A
- Revenue Next Year
- EVGN $78.26
- PMCB N/A
- P/E Ratio
- EVGN N/A
- PMCB $1.00
- Revenue Growth
- EVGN 50.90
- PMCB N/A
- 52 Week Low
- EVGN $1.20
- PMCB $1.22
- 52 Week High
- EVGN $9.00
- PMCB $2.55
- Technical
- Relative Strength Index (RSI)
- EVGN 36.50
- PMCB 33.22
- Support Level
- EVGN $1.32
- PMCB $1.22
- Resistance Level
- EVGN $1.38
- PMCB $1.58
- Average True Range (ATR)
- EVGN 0.07
- PMCB 0.14
- MACD
- EVGN -0.01
- PMCB -0.04
- Stochastic Oscillator
- EVGN 18.52
- PMCB 15.59
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.